Lakefront Biotherapeutics NV
LKFT
$27.22
-$0.21-0.77%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 06/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 292.58M | 292.58M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | 292.58M | 292.58M |
| Cost of Revenue | -- | -- | -- | 468.84M | 534.33M |
| Gross Profit | -- | -- | -- | -176.26M | -241.74M |
| SG&A Expenses | -- | -- | -- | 133.77M | 152.61M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -41.57M | -41.57M |
| Total Operating Expenses | -- | -- | -- | 561.03M | 645.36M |
| Operating Income | -- | -- | -- | -268.45M | -352.78M |
| Income Before Tax | -- | -- | -- | -316.07M | -316.07M |
| Income Tax Expenses | -- | -- | -- | -2.55M | -2.55M |
| Earnings from Continuing Operations | -- | -- | -- | -313.52 | -313.52 |
| Earnings from Discontinued Operations | -- | -- | -- | 1.97M | 1.97M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | -- | -311.54M | -311.54M |
| EBIT | -- | -- | -- | -268.45M | -352.78M |
| EBITDA | -- | -- | -- | -215.66M | -299.98M |
| EPS Basic | -- | -- | -- | -4.73 | -4.73 |
| Normalized Basic EPS | -- | -- | -- | -1.35 | -2.40 |
| EPS Diluted | -- | -- | -- | -4.73 | -4.73 |
| Normalized Diluted EPS | -- | -- | -- | -1.35 | -2.40 |
| Average Basic Shares Outstanding | -- | -- | -- | 263.63M | 263.63M |
| Average Diluted Shares Outstanding | -- | -- | -- | 263.68M | 263.68M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |